Author:
Santos Stephanie,Yang Eddy S.
Reference119 articles.
1. Strategies for the successful implementation of plasma-based NSCLC genotyping in clinical practice;Aggarwal;Nature Reviews. Clinical Oncology,2021
2. Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases;Allard;Clinical Cancer Research,2004
3. Next-generation sequencing of circulating tumor DNA for early cancer detection;Aravanis;Cell,2017
4. Molecular detection of minimal residual disease in multiple myeloma;Bai;British Journal of Haematology,2018
5. Tumor epidermal growth factor receptor (EGFR) expression levels does not predict for response in patients (pts) receiving gefitinib (“Iressa,” ZD1839) monotherapy for pretreated advanced non-small-cell lung cancer (NSCLC): IDEAL 1 and 2;Bailey;Proceedings of the American Association for Cancer Research,2003